Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of  diabetes such as  diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.

Scope of the Report:

This report focuses on the Insulin Drug and Delivery Technologies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future. 

The worldwide market for Insulin Drug and Delivery Technologies is expected to grow at a CAGR of roughly 9.2% over the next five years, will reach 55900 million US$ in 2023, from 36000 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Sanofi

Eli Lilly and Company

Biocon

Julphar

Ypsomed

Becton, Dickinson and Company

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Insulin Syringes

Insulin Vials

Insulin Pens

Insulin Pumps

Market Segment by Applications, can be divided into

Diabetes Mellitus Type 1

Diabetes Mellitus Type 2

Gestational Diabetes

There are 15 Chapters to deeply display the global Insulin Drug and Delivery Technologies market.

Chapter 1, to describe Insulin Drug and Delivery Technologies Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Insulin Drug and Delivery Technologies, with sales, revenue, and price of Insulin Drug and Delivery Technologies, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Insulin Drug and Delivery Technologies, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Insulin Drug and Delivery Technologies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Insulin Drug and Delivery Technologies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

These dominant industry players use well planned strategies to occupied highest market share in this market. Some of the top players in [Keyword] business includes. [Company list]
As per [Keyword] market analysis, North America is forecasted to occupied major share in the [Keyword] market.
The statistical data of the dominant industry player of [Keyword] market can be acquired from the company profile segment described in the report. This segment come up with analysis of major player’s in the [Keyword] market, also their last five-year revenue, segmental, product offerings, key strategies adopted and geographical revenue produced.
The report come up with a segment of the [Keyword] market based on Type, Region, and Application, Also offer a determined view on the [Keyword] market.
The report offers a nitty-gritty estimation of the market by providing data on various viewpoints that incorporate, restraints, drivers, and opportunities threats. This data can help in making suitable decisions for stakeholders before investing.
The sample report for [Keyword] market can be received after the apply from the website.

Table Of Content

Table of Contents



1 Market Overview

    1.1 Insulin Drug and Delivery Technologies Introduction

    1.2 Market Analysis by Type

        1.2.1 Insulin Syringes

        1.2.2 Insulin Vials

        1.2.3 Insulin Pens

        1.2.4 Insulin Pumps

    1.3 Market Analysis by Applications

        1.3.1 Diabetes Mellitus Type 1

        1.3.2 Diabetes Mellitus Type 2

        1.3.3 Gestational Diabetes

    1.4 Market Analysis by Regions

        1.4.1 North America (United States, Canada and Mexico)

            1.4.1.1 United States Market States and Outlook (2013-2023)

            1.4.1.2 Canada Market States and Outlook (2013-2023)

            1.4.1.3 Mexico Market States and Outlook (2013-2023)

        1.4.2 Europe (Germany, France, UK, Russia and Italy)

            1.4.2.1 Germany Market States and Outlook (2013-2023)

            1.4.2.2 France Market States and Outlook (2013-2023)

            1.4.2.3 UK Market States and Outlook (2013-2023)

            1.4.2.4 Russia Market States and Outlook (2013-2023)

            1.4.2.5 Italy Market States and Outlook (2013-2023)

        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

            1.4.3.1 China Market States and Outlook (2013-2023)

            1.4.3.2 Japan Market States and Outlook (2013-2023)

            1.4.3.3 Korea Market States and Outlook (2013-2023)

            1.4.3.4 India Market States and Outlook (2013-2023)

            1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

        1.4.4 South America, Middle East and Africa

            1.4.4.1 Brazil Market States and Outlook (2013-2023)

            1.4.4.2 Egypt Market States and Outlook (2013-2023)

            1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

            1.4.4.4 South Africa Market States and Outlook (2013-2023)

            1.4.4.5 Nigeria Market States and Outlook (2013-2023)

    1.5 Market Dynamics

        1.5.1 Market Opportunities

        1.5.2 Market Risk

        1.5.3 Market Driving Force

2 Manufacturers Profiles

    2.1 Sanofi

        2.1.1 Business Overview

        2.1.2 Insulin Drug and Delivery Technologies Type and Applications

            2.1.2.1 Product A

            2.1.2.2 Product B

        2.1.3 Sanofi Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.2 Eli Lilly and Company

        2.2.1 Business Overview

        2.2.2 Insulin Drug and Delivery Technologies Type and Applications

            2.2.2.1 Product A

            2.2.2.2 Product B

        2.2.3 Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.3 Biocon

        2.3.1 Business Overview

        2.3.2 Insulin Drug and Delivery Technologies Type and Applications

            2.3.2.1 Product A

            2.3.2.2 Product B

        2.3.3 Biocon Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.4 Julphar

        2.4.1 Business Overview

        2.4.2 Insulin Drug and Delivery Technologies Type and Applications

            2.4.2.1 Product A

            2.4.2.2 Product B

        2.4.3 Julphar Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.5 Ypsomed

        2.5.1 Business Overview

        2.5.2 Insulin Drug and Delivery Technologies Type and Applications

            2.5.2.1 Product A

            2.5.2.2 Product B

        2.5.3 Ypsomed Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.6 Becton, Dickinson and Company

        2.6.1 Business Overview

        2.6.2 Insulin Drug and Delivery Technologies Type and Applications

            2.6.2.1 Product A

            2.6.2.2 Product B

        2.6.3 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Insulin Drug and Delivery Technologies Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    3.1 Global Insulin Drug and Delivery Technologies Sales and Market Share by Manufacturer (2016-2017)

    3.2 Global Insulin Drug and Delivery Technologies Revenue and Market Share by Manufacturer (2016-2017)

    3.3 Market Concentration Rate

        3.3.1 Top 3 Insulin Drug and Delivery Technologies Manufacturer Market Share in 2017

        3.3.2 Top 6 Insulin Drug and Delivery Technologies Manufacturer Market Share in 2017

    3.4 Market Competition Trend

4 Global Insulin Drug and Delivery Technologies Market Analysis by Regions

    4.1 Global Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Regions

        4.1.1 Global Insulin Drug and Delivery Technologies Sales and Market Share by Regions (2013-2018)

        4.1.2 Global Insulin Drug and Delivery Technologies Revenue and Market Share by Regions (2013-2018)

    4.2 North America Insulin Drug and Delivery Technologies  Sales and Growth Rate (2013-2018)

    4.3 Europe Insulin Drug and Delivery Technologies  Sales and Growth Rate (2013-2018)

    4.4 Asia-Pacific Insulin Drug and Delivery Technologies  Sales and Growth Rate (2013-2018)

    4.5 South America Insulin Drug and Delivery Technologies  Sales and Growth Rate (2013-2018)

    4.6 Middle East and Africa Insulin Drug and Delivery Technologies  Sales and Growth Rate (2013-2018)

5 North America Insulin Drug and Delivery Technologies by Countries

    5.1 North America Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries

        5.1.1 North America Insulin Drug and Delivery Technologies Sales and Market Share by Countries (2013-2018)

        5.1.2 North America Insulin Drug and Delivery Technologies Revenue and Market Share by Countries (2013-2018)

    5.2 United States Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    5.3 Canada Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    5.4 Mexico Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

6 Europe Insulin Drug and Delivery Technologies by Countries

    6.1 Europe Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries

        6.1.1 Europe Insulin Drug and Delivery Technologies Sales and Market Share by Countries (2013-2018)

        6.1.2 Europe Insulin Drug and Delivery Technologies Revenue and Market Share by Countries (2013-2018)

    6.2 Germany Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    6.3 UK Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    6.4 France Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    6.5 Russia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    6.6 Italy Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

7 Asia-Pacific Insulin Drug and Delivery Technologies by Countries

    7.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries

        7.1.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales and Market Share by Countries (2013-2018)

        7.1.2 Asia-Pacific Insulin Drug and Delivery Technologies Revenue and Market Share by Countries (2013-2018)

    7.2 China Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    7.3 Japan Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    7.4 Korea Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    7.5 India Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    7.6 Southeast Asia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

8 South America Insulin Drug and Delivery Technologies by Countries

    8.1 South America Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries

        8.1.1 South America Insulin Drug and Delivery Technologies Sales and Market Share by Countries (2013-2018)

        8.1.2 South America Insulin Drug and Delivery Technologies Revenue and Market Share by Countries (2013-2018)

    8.2 Brazil Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    8.3 Argentina Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    8.4 Colombia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

9 Middle East and Africa Insulin Drug and Delivery Technologies by Countries

    9.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Countries

        9.1.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales and Market Share by Countries (2013-2018)

        9.1.2 Middle East and Africa Insulin Drug and Delivery Technologies Revenue and Market Share by Countries (2013-2018)

    9.2 Saudi Arabia Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    9.3 UAE Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    9.4 Egypt Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    9.5 Nigeria Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

    9.6 South Africa Insulin Drug and Delivery Technologies Sales and Growth Rate (2013-2018)

10 Global Insulin Drug and Delivery Technologies Market Segment by Type

    10.1 Global Insulin Drug and Delivery Technologies Sales, Revenue and Market Share by Type (2013-2018)

        10.1.1 Global Insulin Drug and Delivery Technologies Sales and Market Share by Type (2013-2018)

        10.1.2 Global Insulin Drug and Delivery Technologies Revenue and Market Share by Type (2013-2018)

    10.2 Insulin Syringes Sales Growth and Price

        10.2.1 Global Insulin Syringes Sales Growth (2013-2018)

        10.2.2 Global Insulin Syringes Price (2013-2018)

    10.3 Insulin Vials Sales Growth and Price

        10.3.1 Global Insulin Vials Sales Growth (2013-2018)

        10.3.2 Global Insulin Vials Price (2013-2018)

    10.4 Insulin Pens Sales Growth and Price

        10.4.1 Global Insulin Pens Sales Growth (2013-2018)

        10.4.2 Global Insulin Pens Price (2013-2018)

    10.5 Insulin Pumps Sales Growth and Price

        10.5.1 Global Insulin Pumps Sales Growth (2013-2018)

        10.5.2 Global Insulin Pumps Price (2013-2018)

11 Global Insulin Drug and Delivery Technologies Market Segment by Application

    11.1 Global Insulin Drug and Delivery Technologies Sales Market Share by Application (2013-2018)

    11.2 Diabetes Mellitus Type 1 Sales Growth (2013-2018)

    11.3 Diabetes Mellitus Type 2 Sales Growth (2013-2018)

    11.4 Gestational Diabetes Sales Growth (2013-2018)

12 Insulin Drug and Delivery Technologies Market Forecast (2018-2023)

    12.1 Global Insulin Drug and Delivery Technologies Sales, Revenue and Growth Rate (2018-2023)

    12.2 Insulin Drug and Delivery Technologies Market Forecast by Regions (2018-2023)

        12.2.1 North America Insulin Drug and Delivery Technologies Market Forecast (2018-2023)

        12.2.2 Europe Insulin Drug and Delivery Technologies Market Forecast (2018-2023)

        12.2.3 Asia-Pacific Insulin Drug and Delivery Technologies Market Forecast (2018-2023)

        12.2.4 South America Insulin Drug and Delivery Technologies Market Forecast (2018-2023)

        12.2.5 Middle East and Africa Insulin Drug and Delivery Technologies Market Forecast (2018-2023)

    12.3 Insulin Drug and Delivery Technologies Market Forecast by Type (2018-2023)

        12.3.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Type (2018-2023)

        12.3.2 Global Insulin Drug and Delivery Technologies Market Share Forecast by Type (2018-2023)

    12.4 Insulin Drug and Delivery Technologies Market Forecast by Application (2018-2023)

        12.4.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Application (2018-2023)

        12.4.2 Global Insulin Drug and Delivery Technologies Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

    13.1 Sales Channel

        13.1.1 Direct Marketing

        13.1.2 Indirect Marketing

        13.1.3 Marketing Channel Future Trend

    13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

    15.1 Methodology

    15.2 Data Source

Inquiry For Buying

Insulin Drug and Delivery Technologies

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

Insulin Drug and Delivery Technologies

Please fill out the form. We will contact you within 24 hours:
All fields required...

×

Avail Free PDF Sample Report

This website is secure and your personal details are safe. Privacy Policy

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you

Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com